A new Medicare initiative launched this summer is expanding access to weight-loss medications by offering eligible beneficiaries a heavily subsidized monthly cost of just $50. Pharmacy chains CVS and Walgreens report filling over 100,000 prescriptions each under the program since its start, signaling strong early demand. The move aims to address rising obesity rates by making these treatments more affordable for those who qualify. Details on long-term impact and eligibility criteria remain key questions as the program continues.
The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and Walgreens say they've each already filled 100,000 such prescriptions.
